Cardiovascular Research Advance Access originally published online on December 12, 2007
Cardiovascular Research 2008 78(1):90-97; doi:10.1093/cvr/cvm100
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disruption of phospholipase C
1 signalling attenuates cardiac tumor necrosis factor-
expression and improves myocardial function during endotoxemia
1 Center for Critical Illness Research, Lawson Health Research Institute, VRL 6th Floor, 800 Commissioners Road, London, Ontario, Canada N6A 4G5
2 Department of Medicine
3 Department of Pathology
4 Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada N6A 4G5
* Corresponding authors. Tel: +1 519 685 8300 Ext. 55441; fax: +1 519 685 8341. E-mail address: tpeng2{at}uwo.ca; qfeng{at}uwo.ca
Aims: Lipopolysaccharide (LPS) induces tumor necrosis factor-
(TNF-
) expression in cardiomyocytes, which contributes to myocardial dysfunction during sepsis. The purpose of this study was to investigate the role of phosphatidylinositol (PI) phospholipase C
1 (PLC
1) in cardiac TNF-
expression, and myocardial dysfunction during endotoxemia.
Methods and results: In cultured mouse neonatal cardiomyocytes, LPS increased PLC
1 phosphorylation. Knockdown of PLC
1 with specific siRNA or inhibition of PLC
1 with U73122
[GenBank]
attenuated TNF-
expression induced by LPS. This action of PLC
1 was mediated through inositol-1,4,5-trisphosphate (IP3)/IP3 receptor (IP3R) pathways since blocking either IP3 or IP3R decreased LPS-induced TNF-
expression. In contrast, neither diacylglycerol agonist nor antagonist had any evident effect on LPS-induced TNF-
expression in cardiomyocytes. To investigate the role of PLC
1 in endotoxemia in vivo, wild-type and heterozygous PLC
1 knockout (PLC
1+/–) mice were pre-treated with either U73122
[GenBank]
, or its inactive analog U73343
[GenBank]
, or vehicle for 15 min, followed by LPS for 4 h. Inhibition of PLC
1 by U73122
[GenBank]
or by heterozygous deletion of the PLC
1 gene decreased cardiac TNF-
expression. More importantly, LPS-induced myocardial dysfunction was also attenuated in PLC
1+/– mice or by U73122
[GenBank]
treatment.
Conclusion: PLC
1 signalling induces cardiac TNF-
expression and myocardial dysfunction during LPS stimulation. The action of PLC
1 on TNF-
expression is mediated through IP3/IP3R pathways. The present results suggest that PLC
1 may be a potential therapeutic target for myocardial dysfunction in sepsis.
KEYWORDS Sepsis; Cytokine; Cardiomyocytes; Contractility; Phospholipase-C
Time for primary review: 32 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Li, Y. Li, Q. Feng, M. Arnold, and T. Peng Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes Cardiovasc Res, October 1, 2009; 84(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
